Globally, the interventional radiology products market
is witnessing moderate growth due to factors such as rising incidence of chronic
diseases, rising geriatric population, and increasing demand for minimally
invasive surgeries.
On the other hand, availability of cost-effective conventional first-level
treatments and product failures and recalls are the key restraining factors to
the growth of this market. The high growth potential in the emerging regions
like Asia provides growth opportunities for players operating in the interventional
radiology products market.
Based on type, the interventional
radiology products market is segmented into stents, catheters,
IVC filters, hemodynamic flow alteration devices, angioplasty balloons, thrombectomy
systems, embolization devices, biopsy needles, and accessories. In 2016, the stents
segment is expected to account for the largest share of the market. The key
factors driving the growth of the interventional radiology stents market are
the growing geriatric population and increasing incidence of cardiovascular
diseases around the world.
Based on procedure, the interventional radiology products market is segmented
into angioplasty, angiography, embolization, thrombolysis, biopsy & drainage,
vertebroplasty, nephrostomy, and other procedures. In 2016, the angiography segment
is expected to account for the largest share of the market. The increasing
prevalence of these conditions and the growing demand for minimally invasive
procedures are the key factors driving market growth in this segment.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=67681703
Based on application, the market is segmented into cardiology, urology & nephrology,
oncology, gastroenterology, neurology, orthopedics, and other
applications. The oncology segment is expected to grow at the highest CAGR
during the forecast period. The major factors driving the growth of this market
segment are the increasing incidence of cancer and rising demand for minimally
invasive procedures.
Based on region, the interventional radiology products market is segmented into
North America, Europe, Asia and Rest of the World (RoW). In 2016, North America
is expected to dominate the interventional radiology products market while Asia
is expected to grow at the highest CAGR during the forecast period. The high
growth of this geographic segment is attributed to the increasing prevalence of
chronic diseases and growing geriatric population in Asia. The market is
further driven by factors such as increasing reimbursement for minimally
invasive procedures.